Although this work explains that aberrantly expressed genes in PV could not only be attributed to mutated JAK2 signaling, many of them are deregulated by JAK2-independent unknown mechanisms, opening a new horizon in the pathogenesis of PV, since, as mentioned above, almost 95% of PV patients harbor JAK2 mutations [5]. The gene discussed is JAK2; the disease is acquired polycythemia vera.